ID   CHO/CLDN5
AC   CVCL_D3PP
SY   CLDN5/CHO
RX   Patent=US8076458;
RX   PubMed=19555390;
RX   PubMed=25744656;
CC   Transfected with: HGNC; 2047; CLDN5 (with a C-terminal mycHis6 tag).
CC   Transfected with: UniProtKB; P00552; Transposon Tn5 neo.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_7180 ! CHO-DG44
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 30-01-24; Last updated: 30-01-24; Version: 1
//
RX   Patent=US8076458;
RA   Ohta S., Ando H., Suzuki M., Kawamoto S., Kato-Nakano M., Nakamura K.;
RT   "Anti-claudin-4 antibody.";
RL   Patent number US8076458, 13-Dec-2011.
//
RX   PubMed=19555390; DOI=10.1111/j.1349-7006.2009.01239.x;
RA   Suzuki M., Kato-Nakano M., Kawamoto S., Furuya A., Abe Y., Misaka H.,
RA   Kimoto N., Nakamura K., Ohta S., Ando H.;
RT   "Therapeutic antitumor efficacy of monoclonal antibody against
RT   claudin-4 for pancreatic and ovarian cancers.";
RL   Cancer Sci. 100:1623-1630(2009).
//
RX   PubMed=25744656; DOI=10.1080/09168451.2015.1018124;
RA   Ando H., Suzuki M., Kato-Nakano M., Kawamoto S., Misaka H., Kimoto N.,
RA   Furuya A., Nakamura K.;
RT   "Generation of specific monoclonal antibodies against the
RT   extracellular loops of human claudin-3 by immunizing mice with
RT   target-expressing cells.";
RL   Biosci. Biotechnol. Biochem. 79:1272-1279(2015).
//